Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
17.63
+0.24 (1.38%)
At close: Jun 26, 2026, 4:00 PM EDT
17.62
-0.01 (-0.06%)
After-hours: Jun 26, 2026, 5:08 PM EDT
Theravance Biopharma Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Theravance Biopharma stock have an average target of 16.78, with a low estimate of 13.67 and a high estimate of 21. The average target predicts a decrease of -4.82% from the current stock price of 17.63.
Analyst Consensus: Buy
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Theravance Biopharma stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $18 → $19 | Buy | Reiterates | $18 → $19 | +7.77% | May 28, 2026 |
| BTIG | BTIG | Buy Maintains $21 | Buy | Maintains | $21 | +19.12% | May 8, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $15 | Hold | Reiterates | $15 | -14.92% | May 8, 2026 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | -3.57% | Apr 7, 2026 |
| Oppenheimer | Oppenheimer | Hold Downgrades $27 → $14 | Hold | Downgrades | $27 → $14 | -22.46% | Mar 5, 2026 |
Financial Forecast
Revenue This Year
84.13M
from 107.46M
Decreased by -21.71%
Revenue Next Year
96.83M
from 84.13M
Increased by 15.09%
EPS This Year
0.21
from -0.15
EPS Next Year
1.26
from 0.21
Increased by 497.62%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 93.7M | 146.0M | |
| Avg | 84.1M | 96.8M | |
| Low | 77.4M | 78.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -12.8% | 73.5% | |
| Avg | -21.7% | 15.1% | |
| Low | -28.0% | -6.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 0.21 | 1.26 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | 497.6% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.